Profil
Richard L.
Rudolph joined Cyberonics, Inc. in August 2001 as Vice President of Clinical, Regulatory and Medical Affairs and Chief Medical Officer.
He was Senior Director of Clinical Research and Development for Wyeth-Ayerst Research.
Ehemalige bekannte Positionen von Richard L. Rudolph
| Unternehmen | Position | Ende |
|---|---|---|
| CYBERONICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2008 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
LivaNova USA, Inc.
 LivaNova USA, Inc. Medical SpecialtiesHealth Technology LivaNova USA, Inc. engages in the design, development, sales, and marketing of implantable medical devices. It operates through providing neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy) for the treatment of refractory epilepsy, and treatment-resistant depression (TRD). The company was founded in 1987 and is headquartered in Granbury, TX. | Health Technology |
